Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1188 results for "us food drug administration"

John Larkin to Receive Food Safety Magazine Distinguished Service Award
Food Safety Magazine

FDA Final Menu Guidance Largely Unchanged from 2015 Draft

The U.S. Food and Drug Administration late Friday published its final menu labeling guidance for the food industry, apparently ignoring concerns that grocery stores are being lumped in under regulations designed for restaurants. The guidance is ... Progressive Grocer, 17 hours ago
[x]  
Moneycontrol.com

India : AUROBINDO PHARMA gets terminal USFDA affirmation for Esomeprazole Magnesium Delayed-release Capsules [TendersInfo (India)]

Aurobindo Pharma Limited has gained last sanctioning from the US Food & Drug Administration (USFDA) to manufacture and market Esomeprazole Magnesium Delayed-release Capsules USP, 20 mg and 40 mg. The launch of this item is depended on the ...
 Pharmacy Choice3 hours ago Glenmark receives tentative US FDA approval for generic Epiduo gel  PharmaBiz1 day ago GLENMARK GETS USFDA NOD FOR ORAL CONTRACEPTIVES  Pharmacy Choice1 day ago Aurobindo Pharma gets final approval for Lascoamide Tablets  HDFC Securities1 day ago
[x]  

U.S. approves Acadia drug for Parkinson's disease-linked psychosis

(Reuters) - Acadia Pharmaceuticals Inc's drug for psychosis linked to Parkinson's disease was approved by the U.S. Food and Drug Administration on Friday, becoming the first ever treatment to get a U.S. nod for the condition. The regulator, ...
 Business Insider17 hours ago U.S. approves first drug for psychosis linked to Parkinson's  Sharenet17 hours ago US approves Acadia drug for Parkinson's disease-linked psychosis  Channel NewsAsia17 hours ago US approves first drug for psychosis linked to Parkinson's  The Malaysian Times14 hours ago
[x]  
CNBC

Quest Diagnostics' Zika RT-PCR test receives US FDA emergency use authorization

Quest Diagnostics, the world's leading provider of diagnostic information services, has received a US Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test).
 PharmaBiz6 hours ago Quest approved for Zika diagnostic test  Northern Territory News1 day ago Quest Diagnostics says its Zika virus test gets US approval  CNBC1 day ago Zika virus test gets U.S. approval  Japan Times1 day ago
[x]  
Reuters

FDA Proposes Ban on Electrical Stimulation Devices for Aggressive or Self-Injurious Behavior

On April 25, the U.S. Food and Drug Administration published a proposed rule banning electrical stimulation devices (ESDs) used to treat aggressive or self-injurious behavior. ESDs have been used to reduce or eliminate self-injurious or ...
 Lexology15 hours ago US FDA proposes ban on electrical stimulation devices intended to treat self-injurious or aggressive behaviour  PharmaBiz5 days ago FDA proposes ban on certain electrical stimulation devices  Reuters1 week ago WASHINTON, 22nd April, 2016 (WAM)The U.S. Food and Drug Administration today announced a proposal ...  Federation of Arab News Agencies1 week ago
Tech Times

Another Fatal-Disease Drug in Limbo

WIKIMEDIAAn advisory panel for the US Food and Drug Administration (FDA) voted this week (April 25) that Sarepta Therapeutics's eteplirsen has not been proven effective in the treatment of Duchenne muscular dystrophy (DMD), a rare and fatal disease ...
 The Scientist3 days ago FDA Panel Gives Thumbs Down To Sarepta Duchenne Muscular Dystrophy Drug Eteplirsen  Tech Times3 days ago US panel says Sarepta's trial DMD drug not proven effective  Pharmafile4 days ago U.S. panel: Sarepta Duchenne drug not proven effective  Sharenet4 days ago
[x]  

Boston Scientific's ImageReady MR-Conditional Pacing System receives US FDA approval

Boston Scientific, a global medical technology leader, has received US Food and Drug Administration (FDA) approval for a suite of products deemed safe for use in a magnetic resonance imaging (MRI) environment. The ImageReady MR-Conditional Pacing ...
 PharmaBiz3 days ago Boston Scientific Receives U.S. FDA Approval For ImageReady(TM) MR-Conditional Pacing System  Healthcare Sales & Marketing Network18 hours ago Stock Update (NYSE:BSX): Boston Scientific Receives U.S. FDA Approval For ImageReady MR-Conditional Pacing System  MoneyShow.com4 days ago BOSTON SCIENTIFIC : Receives U.S. FDA Approval For ImageReady MR-Conditional Pacing System  4 Traders4 days ago
[x]  
Reuters

GW Pharma's cannabis drug gets orphan drug status

The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease. GW said on Thursday that its drug, Epidiolex, ...
 Reuters1 week ago GW Pharmaceuticals gets Orphan Drug status from US FDA for cannabidiol to treat tuberous sclerosis complex  PharmaBiz1 week ago Orphan Drug Designation for GW's cannabis seizure treatment  MENAFN3 days ago US FDA grants 7-year Orphan Drug exclusivity to Spectrum Pharma's Evomela for multiple myeloma  PharmaBiz1 week ago

Panic signals in India as USFDA asks drug companies to repeat Semler's studies

MUMBAI|NEW DELHI: A note from the US Food and Drug Administration (FDA) informing drug companies last week about data integrity concerns at Semler Research has sent panic signals across the Indian pharmaceutical industry. The US agency had called ...
 Economic Times5 days ago FDA warns Semler over research data  The Hindu1 week ago US Food and Drug Administration issues data integrity notice to Indian CRO Semler  Economic Times1 week ago
Reuters

US FDA grants breakthrough therapy designations for Novartis' Ilaris to treat rare types of periodic fever syndromes

The US Food and Drug Administration (FDA) has granted three Breakthrough Therapy Designations for Novartis' Ilaris (canakinumab) to treat three rare types of periodic fever syndromes, also known as hereditary periodic fevers. This means Novartis ...
 PharmaBiz2 days ago US Breakthrough designations granted for Novartis Ilaris for rare periodic fever syndromes  Pharma Letter2 days ago Novartis Ilaris gets US FDA breakthrough therapy designation to treat fever syndromes  Pharmafile3 days ago FDA gives ocrelizumab breakthrough designation for PPMS: Roche  Reuters2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - us food drug administration
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less